v3.22.2.2
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 26, 2022
Mar. 15, 2022
Feb. 14, 2022
Dec. 22, 2021
Dec. 02, 2021
Aug. 19, 2021
May 18, 2021
Oct. 01, 2020
Sep. 02, 2020
Aug. 03, 2020
Jul. 31, 2020
Jul. 28, 2020
Jun. 08, 2020
Apr. 06, 2020
Jan. 09, 2020
Dec. 21, 2021
Sep. 29, 2021
May 18, 2021
Sep. 25, 2020
Jul. 31, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Stockholders' Equity (Details) [Line Items]                                                    
Preferred stock, shares authorized                                         25,000,000   25,000,000   25,000,000 25,000,000
Preferred stock, par value per share (in Dollars per share)                                         $ 0.001   $ 0.001   $ 0.001 $ 0.001
Preferred stock, shares outstanding                                         0   0   0 0
Common stock, shares authorized                                         18,750,000   18,750,000   18,750,000 18,750,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)                                         $ 0.001   $ 0.001   $ 0.001 $ 0.001
Common stock, shares outstanding       10,132,047                                 10,207,212   10,207,212   10,207,212  
Exercised                                             75,000      
Additional shares         49,444   1,325,000                                      
Shares available for grant                                         256,014   256,014   318,514  
Granted purchased shares                                             100,000   383,125  
Gross proceeds from sale of equity (in Dollars)                                             $ 5,000,000   $ 17,250,000  
Restricted stock award net of forfeitures (in Dollars)                                             $ 295,750    
Class of warrant or right, outstanding                                         4,813,836   4,813,836   3,036,185  
Exercise price of warrants or rights (in Dollars per share)                                                 $ 20  
Warrants exercisable term                                             5 years      
Warrants liabilities (in Dollars)                                         $ 1,792,000 $ (278,000) $ 3,622,000 (278,000) $ 1,387,000
Salary expenses (in Dollars)           $ 30,000                             902,106 683,197 1,817,746 1,567,238 2,887,309 915,210
Professional fees (in Dollars)                                         873,865 455,552 1,417,905 984,625 $ 2,269,756 1,153,731
Warrants to purchase common shares                                                 749,984  
Share based payment arrangement, expense (in Dollars)                                         676,242 $ 194,657 1,392,674 $ 562,375    
Unrecognized compensation cost, non vested (in Dollars)                                         $ 2,154,935   $ 2,154,935      
Unrecognized compensation, weighted average period                                             1 year 10 months 6 days      
Common stock, shares issued       10,132,047                                            
Stock issued during period, shares, new issues       1,150,000                 5,000 40,000 31,250                      
Stock issued during period, value, new issues (in Dollars)                         $ 20,200 $ 161,600 $ 126,250                     6,275,164
Exercise of stock options                           1,250                        
Stock issued during period services, value (in Dollars)                                                   237,500
Stock issued during period, value, conversion of convertible securities (in Dollars)                                                   261,453
Stock issued during period acquisition, value (in Dollars)                                                 $ 7,774,000 $ 12,500,000
Secured Borrowings, Gross, Difference, Amount (in Dollars)                                     $ 1,237,760              
Shares of common stock               5,000                     247,552            
Net amount (in Dollars)                                     $ 1,116,566              
Common stock price (in Dollars per share)               $ 5                                    
Warrant share               9,091                                    
Exercise price (in Dollars per share)               $ 5.5                                    
Stock incentive plan description                                   the Marizyme, Inc. Amended and Restated 2021 Stock Incentive Plan (“SIP”). The SIP incorporates stock options issued prior to May 18, 2021. The SIP authorized 1,325,000 options for issuance. As of December 31, 2021, there remains 412,264 options available for issuance.                
Granted shares                                                 383,125 335,000
Aggregate shares                                 261,387                  
strike price (in Dollars per share)                                 $ 9                  
Warrant term                                 5 years                  
Exchange agreements description                               On December 21, 2021, pursuant to the December 2021 Exchange Agreements (Note 6) all previously issued Original Class C warrants were replaced with an aggregate of 416,011 pro-rata New Class C warrants with an exercise price of $9.00 per share (unchanged) and a five-year life measured from the date of the December 2021 Exchange Agreements. The decrease in the Unit price also resulted in additional number of New Class C Warrants being issued in exchange for the Original Class C Warrants due to the 200% warrant coverage provided for in the Unit Purchase Agreement. On December 21, 2021, pursuant to the December 2021 Unit Purchase Agreement the Company issued additional 1,714,286 New Class C warrants with an exercise price of $9.00 per share and a term of five years. The detachable warrants issued were accounted for as an equity instrument and were ascribed an aggregate fair market value of $4,447,982 using the residual fair value allocation method.                     
Somah acquisition description                                       On July 31, 2020, the Company completed the Somah Acquisition (Note 2) whereas 2,500,000 shares of common stock and 749,984 warrants were issued. The warrants have a strike price of $20.00 per share and a term of five years. The valuation of the warrants granted was completed during the year ended December 31, 2021, and the fair market value was determined to be $1.60 per share or $1,200,000.             
Warrant Purchase                                     28,001              
Fair market value description                                     The fair market value was determined to be $3.625 per share or $152,249 and $101,500, respectively, or $253,749, collectively.              
Stock-based compensation description                                                 During the year ended December 31, 2021, the Company recorded $865,111 in non-cash share-based compensation (2020 - $1,833,292). Additionally, the Company recognized $33,333 of stock-based compensation on restricted common stock in the year ended December 31, 2021.  
Common Stock [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Common stock, shares outstanding                                                 8,982,212 8,982,212
Common stock, shares issued                                                 10,132,212  
Stock issued during period, value, new issues (in Dollars)                                                   $ 1,400
Stock issued during period, shares, services                                                   53,750
Stock issued during period services, value (in Dollars)                                                   $ 54
Stock issued during period, shares, conversion of convertible securities                                                   63,514
Stock issued during period, value, conversion of convertible securities (in Dollars)                                                   $ 64
Issuance of common stock for acquisition, shares                                                 1,150,000 2,500,000
Stock issued during period acquisition, value (in Dollars)                                                 $ 1,150 $ 2,500
Private placement description                   ●On August 3, 2020, the Company completed an initial closing of a private placement pursuant to which the Company sold and issued an aggregate of 1,152,496 shares of its common stock at a purchase price of $5.00 per share. In consideration for services rendered as the placement agent in the private placement, the Company paid Univest Securities LLC cash commissions totaling $460,999, or 8% of the gross proceeds of the private placement closing, a 1% non-accountable expense allowance totaling $57,625, and the $31,250 balance (of a total of $37,500) due to the placement agent in advisory fees. Additionally, the Company issued to the placement agent a five-year warrant to purchase an aggregate of 57,375 shares of the Company’s Common Stock at an exercise price of $5.50 per share. The warrant, for which the placement agent paid the Company $100, may be exercised on a cashless basis.                                
Restricted shares                 10,000                                  
strike price (in Dollars per share)                                     $ 5.5              
Warrant term                                                 4 years 8 months 26 days  
Fair value amount (in Dollars)                                                 $ 368,287  
Warrant [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Shares of common stock                                                 57,499  
strike price (in Dollars per share)                                                 $ 5.56  
Warrant Purchase                                     42,002              
Common stock conversion debt [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Stock issued during period, shares, conversion of convertible securities                       16,014                            
Stock issued during period, value, conversion of convertible securities (in Dollars)                       $ 59,453                            
Unit Purchase Agreements Warrants [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Unit purchase agreements warrants description                                                 Pursuant to the May Unit Purchase Agreement (Note 6) the Company issued: (i) Class A Warrants for the purchase an aggregate of 117,495 shares of common stock, with a strike price of $12.52 per share and a term of five years, and (ii) Class B Warrants for the purchase an aggregate of 117,495 shares of common stock with a strike price of $20.00 per share and a term of five years.   
Restricted Stock Units (RSUs) [Member] | Common Stock [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Shares of common stock                                                 87,500  
Compensation cost (in Dollars)                                                
Soma acquisition [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Issuance of common stock for acquisition, shares                     2,500,000                              
Stock issued during period acquisition, value (in Dollars)                     $ 12,500,000                              
Univest Securities [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Exercise price of warrants or rights (in Dollars per share) $ 7                                                  
Warrants exercisable term                                             5 years      
Warrants liabilities (in Dollars)                                             $ 1,281,854      
Warrants issued (in Dollars) $ 57,840                                                  
Salary expenses (in Dollars)                                             769,113      
Professional fees (in Dollars)                                             512,471      
Bradely Richmond [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Exercised   75,000                                                
Warrants to purchase     75,000                                              
Exercise price of warrants or rights (in Dollars per share)     $ 0.04                                              
Warrants liabilities (in Dollars)                                             $ 568,677      
Warrants issued (in Dollars) $ 86,760                                                  
Bradely Richmond [Member] | Common Stock [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Warrants to purchase     75,000                                              
Bradely Richmond [Member] | Warrant [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Warrants to purchase 144,600                                                  
Consultant [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Stock issued during period, shares, services                       5,000   3,750                        
Stock issued during period services, value (in Dollars)                       $ 25,000   $ 15,150                        
Unit Purchase Agreement [Member] | Class C Warrants [Member]                                                    
Stockholders' Equity (Details) [Line Items]                                                    
Exercise price of warrants or rights (in Dollars per share)                                         $ 9   $ 9      
Warrants exercisable term                                             5 years      
Warrants to purchase common shares                                         1,661,458   1,661,458